Richard P Fanelli

58744380, Feb 23, 1999

Oct 11, 1996

8/729128

Rudolf Schohe-Loop - Wuppertal, DE
Peter-Rudolf Seidel - Koln, DE
William Bullock - Wuppertal, DE
Walter Hubsch - Wuppertal, DE
Achim Feurer - Odenthal, DE
Hans-Georg Lerchen - Koln, DE
Georg Terstappen - Dusseldorf, DE
Joachim Schuhmacher - Wuppertal, DE
Franz-Josef van der Staay - Lohmar/Wahlscheid, DE
Bernard Schmidt - Lindlar, DE
Richard J. Fanelli - Madison CT
Jane C. Chisholm - Clinton CT
Richard T. McCarthy - Madison CT

Bayer Aktiengesellschaft - Leverkusen

A01N 4354
C07D40100
C07D23972

514260

The present invention relates to 2,2'-bridged bis-2,4-diaminoquinazolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides processes for the preparation of the compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.

57565171, May 26, 1998

Oct 25, 1996

8/738124

Rudolf Schohe-Loop - Wuppertal, DE
Peter-Rudolf Seidel - Koln, DE
William Bullock - Wuppertal, DE
Achim Feurer - Odenthal, DE
Georg Terstappen - Dusseldorf, DE
Joachim Schuhmacher - Wuppertal, DE
Franz-Josef van der Staay - Lohmar/Wahlscheid, DE
Bernard Schmidt - Lindlar, DE
Richard J. Fanelli - Madison CT
Jane C. Chisholm - Clinton CT
Richard T. McCarthy - Madison CT

Bayer Aktiengesellschaft - Leverkusen

C07D40102
A61K 3147

514314

The present invention relates to the use of bisquinolines of the general formula ##STR1## in which the substituents mentioned have the meanings given in the description. The invention furthermore relates to new bisquinolines of the general formula (I), to a process for the preparation of the known and the new bisquinolines, to the use of the new bisquinolines as medicaments, to their use for the preparation of medicaments, and to medicaments comprising them.

61748978, Jan 16, 2001

Oct 25, 1996

8/738125

Rudolf Schohe-Loop - Wuppertal, DE
Peter-Rudolf Seidel - Koln, DE
William Bullock - Wuppertal, DE
Achim Feurer - Odenthal, DE
Georg Terstappen - Dusseldorf, DE
Joachim Schuhmacher - Wuppertal, DE
Franz-Josef van der Staay - Lohmar/Wahlscheid, DE
Bernard Schmidt - Lindlar, DE
Richard J. Fanelli - Madison CT
Jane C. Chisholm - Clinton CT
Richard T. McCarthy - Madison CT

Bayer Aktiengesellschaft - Leverkusen

C07D40112
A61K 3147

514312

The present invention relates to bis-(quinolyl)-diamines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides a process for the preparation of the compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.

57391270, Apr 14, 1998

Nov 8, 1996

8/745591

Rudolf Schohe-Loop - Wuppertal, DE
Peter-Rudolf Seidel - Koln, DE
William Bullock - Wuppertal, DE
Gabriele Handke - Wuppertal, DE
Achim Feurer - Odenthal, DE
Wolfgang Roben - Bergisch Gladbach, DE
Georg Terstappen - Dusseldorf, DE
Joachim Schuhmacher - Wuppertal, DE
Franz-Josef van der Staay - Lohmar/Wahlscheid, DE
Bernard Schmidt - Lindlar, DE
Richard J. Fanelli - Madison CT
Jane C. Chisholm - Clinton CT
Richard T. McCarthy - Madison CT

Bayer Aktiengesellschaft - Leverkusen

C07D40302
C07D40314
A61K 31535
A61K 31505

514218

The present invention provides 2,4'-bridged bis-2,4-diaminoquinazolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides a process for the preparation of the compounds of the formula (I), drugs containing said compounds and processes for the preparation of drugs containing said compounds.

57602301, Jun 2, 1998

Oct 11, 1996

8/728927

Rudolf Schohe-Loop - Wuppertal, DE
Peter-Rudolf Seidel - Koln, DE
William Bullock - Wuppertal, DE
Achim Feurer - Odenthal, DE
Hans-Georg Lerchen - Koln, DE
Georg Terstappen - Dusseldorf, DE
Joachim Schuhmacher - Wuppertal, DE
Franz-Josef van der Staay - Lohmar/Wahlscheid, DE
Bernard Schmidt - Lindlar, DE
Richard J. Fanelli - Madison CT
Jane C. Chisholm - Clinton CT
Richard T. McCarthy - Madison CT

Bayer Aktiengesellschaft - Leverkusen

C07D23900
A61K 31505

544284

4,4'-Bridged bis-2,4-diaminoquinazolines of the general formula (I) ##STR1## processes for their preparation and use as agents acting on the potassium channels of the brain.

58665625, Feb 2, 1999

Oct 25, 1996

8/738123

Rudolf Schohe-Loop - Wuppertal, DE
Peter-Rudolf Seidel - Koln, DE
William Bullock - Wuppertal, DE
Achim Feurer - Odenthal, DE
Georg Terstappen - Dusseldorf, DE
Joachim Schuhmacher - Wuppertal, DE
Franz-Josef van der Staay - Lohmar/Wahlscheid, DE
Bernard Schmidt - Lindlar, DE
Richard J. Fanelli - Madison CT
Jane C. Chisholm - Clinton CT
Richard T. McCarthy - Madison CT

Bayer Aktiengesellschaft - Leverkusen

C07D21542
C07D24308
A61K 3147

514183

The present invention relates to ring-bridged bis-quinolines of the general formula (I): ##STR1## in which the indicated substituents are as defined in the description. The invention also provides a process for the preparation of compounds of the formula (I), their use for the preparation of drugs, and drugs containing said compounds.